APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Rabies Vaccine (Vero Cell)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Rabies Vaccine (Vero Cell) Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchHuman Rabies Vaccine (Vero Cell) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rabies Vaccine (Vero Cell) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Human Rabies Vaccine (Vero Cell) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rabies Vaccine (Vero Cell) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rabies Vaccine (Vero Cell) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Human Rabies Vaccine (Vero Cell) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Rabies Vaccine (Vero Cell) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Rabies Vaccine (Vero Cell) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Rabies Vaccine (Vero Cell) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Rabies Vaccine (Vero Cell) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Rabies Vaccine (Vero Cell) include Changchun Zhuoyi Biology, Ningbo Rong'an, Liaoning Chengda, Jilin Huikang Biopharmaceutical Co., Ltd., Hualan Bio-vaccine, Guangzhou Nuocheng, Dalian Yali Peak, Chengdu Kanghua Biology and Serum Institute of India Pvt., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Rabies Vaccine (Vero Cell), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Rabies Vaccine (Vero Cell), also provides the sales of main regions and countries. Of the upcoming market potential for Human Rabies Vaccine (Vero Cell), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Rabies Vaccine (Vero Cell) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Rabies Vaccine (Vero Cell) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Rabies Vaccine (Vero Cell) sales, projected growth trends, production technology, application and end-user industry.

Human Rabies Vaccine (Vero Cell) Segment by Company

Changchun Zhuoyi Biology

Ningbo Rong'an

Liaoning Chengda

Jilin Huikang Biopharmaceutical Co., Ltd.

Hualan Bio-vaccine

Guangzhou Nuocheng

Dalian Yali Peak

Chengdu Kanghua Biology

Serum Institute of India Pvt.

Sanofi Pasteur SA

Bharat Biotech

Bavarian Nordic

Human Rabies Vaccine (Vero Cell) Segment by Type

0.5ml

1ml

Human Rabies Vaccine (Vero Cell) Segment by Application

Hospital

Clinic

Human Rabies Vaccine (Vero Cell) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Vaccine (Vero Cell) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Vaccine (Vero Cell) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Vaccine (Vero Cell).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Rabies Vaccine (Vero Cell) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Rabies Vaccine (Vero Cell) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rabies Vaccine (Vero Cell) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Rabies Vaccine (Vero Cell) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.5ml Major Manufacturers Table 3. 1ml Major Manufacturers Table 4. Global Human Rabies Vaccine (Vero Cell) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Human Rabies Vaccine (Vero Cell) Industry Trends Table 8. Human Rabies Vaccine (Vero Cell) Industry Drivers Table 9. Human Rabies Vaccine (Vero Cell) Industry Opportunities and Challenges Table 10. Human Rabies Vaccine (Vero Cell) Industry Restraints Table 11. Global Human Rabies Vaccine (Vero Cell) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2021-2026) Table 15. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2027-2032) Table 16. Global Human Rabies Vaccine (Vero Cell) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Human Rabies Vaccine (Vero Cell) Sales by Region (2021-2026) & (k units) Table 18. Global Human Rabies Vaccine (Vero Cell) Sales by Region (2027-2032) & (k units) Table 19. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2021-2026) Table 20. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2027-2032) Table 21. Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Human Rabies Vaccine (Vero Cell) Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Manufacturers (2021-2026) Table 25. Global Human Rabies Vaccine (Vero Cell) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Human Rabies Vaccine (Vero Cell) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Human Rabies Vaccine (Vero Cell) Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Human Rabies Vaccine (Vero Cell) Manufacturers, Product Type & Application Table 29. Global Human Rabies Vaccine (Vero Cell) Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Human Rabies Vaccine (Vero Cell) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Human Rabies Vaccine (Vero Cell) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2021-2026) Table 36. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2027-2032) Table 37. Global Human Rabies Vaccine (Vero Cell) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2026) & (k units) Table 39. Global Human Rabies Vaccine (Vero Cell) Sales by Type (2027-2032) & (k units) Table 40. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2021-2026) Table 41. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2027-2032) Table 42. Global Human Rabies Vaccine (Vero Cell) Price by Type (2021-2026) & (US$/unit) Table 43. Global Human Rabies Vaccine (Vero Cell) Price by Type (2027-2032) & (US$/unit) Table 44. Global Human Rabies Vaccine (Vero Cell) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2021-2026) Table 48. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2027-2032) Table 49. Global Human Rabies Vaccine (Vero Cell) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2026) & (k units) Table 51. Global Human Rabies Vaccine (Vero Cell) Sales by Application (2027-2032) & (k units) Table 52. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2021-2026) Table 53. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2027-2032) Table 54. Global Human Rabies Vaccine (Vero Cell) Price by Application (2021-2026) & (US$/unit) Table 55. Global Human Rabies Vaccine (Vero Cell) Price by Application (2027-2032) & (US$/unit) Table 56. Changchun Zhuoyi Biology Company Information Table 57. Changchun Zhuoyi Biology Business Overview Table 58. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolio Table 60. Changchun Zhuoyi Biology Recent Development Table 61. Ningbo Rong'an Company Information Table 62. Ningbo Rong'an Business Overview Table 63. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolio Table 65. Ningbo Rong'an Recent Development Table 66. Liaoning Chengda Company Information Table 67. Liaoning Chengda Business Overview Table 68. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolio Table 70. Liaoning Chengda Recent Development Table 71. Jilin Huikang Biopharmaceutical Co., Ltd. Company Information Table 72. Jilin Huikang Biopharmaceutical Co., Ltd. Business Overview Table 73. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolio Table 75. Jilin Huikang Biopharmaceutical Co., Ltd. Recent Development Table 76. Hualan Bio-vaccine Company Information Table 77. Hualan Bio-vaccine Business Overview Table 78. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolio Table 80. Hualan Bio-vaccine Recent Development Table 81. Guangzhou Nuocheng Company Information Table 82. Guangzhou Nuocheng Business Overview Table 83. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolio Table 85. Guangzhou Nuocheng Recent Development Table 86. Dalian Yali Peak Company Information Table 87. Dalian Yali Peak Business Overview Table 88. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolio Table 90. Dalian Yali Peak Recent Development Table 91. Chengdu Kanghua Biology Company Information Table 92. Chengdu Kanghua Biology Business Overview Table 93. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolio Table 95. Chengdu Kanghua Biology Recent Development Table 96. Serum Institute of India Pvt. Company Information Table 97. Serum Institute of India Pvt. Business Overview Table 98. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolio Table 100. Serum Institute of India Pvt. Recent Development Table 101. Sanofi Pasteur SA Company Information Table 102. Sanofi Pasteur SA Business Overview Table 103. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolio Table 105. Sanofi Pasteur SA Recent Development Table 106. Bharat Biotech Company Information Table 107. Bharat Biotech Business Overview Table 108. Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolio Table 110. Bharat Biotech Recent Development Table 111. Bavarian Nordic Company Information Table 112. Bavarian Nordic Business Overview Table 113. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolio Table 115. Bavarian Nordic Recent Development Table 116. North America Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Human Rabies Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2026) & (k units) Table 119. North America Human Rabies Vaccine (Vero Cell) Sales by Type (2027-2032) & (k units) Table 120. North America Human Rabies Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/unit) Table 121. North America Human Rabies Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/unit) Table 122. North America Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Human Rabies Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2026) & (k units) Table 125. North America Human Rabies Vaccine (Vero Cell) Sales by Application (2027-2032) & (k units) Table 126. North America Human Rabies Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/unit) Table 127. North America Human Rabies Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/unit) Table 128. North America Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. North America Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. North America Human Rabies Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 132. North America Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2026) & (k units) Table 133. North America Human Rabies Vaccine (Vero Cell) Sales by Country (2027-2032) & (k units) Table 134. North America Human Rabies Vaccine (Vero Cell) Sales Price by Country (2021-2026) & (US$/unit) Table 135. North America Human Rabies Vaccine (Vero Cell) Sales Price by Country (2027-2032) & (US$/unit) Table 136. United States Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 137. Canada Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 138. Mexico Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 139. Europe Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Human Rabies Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2026) & (k units) Table 142. Europe Human Rabies Vaccine (Vero Cell) Sales by Type (2027-2032) & (k units) Table 143. Europe Human Rabies Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/unit) Table 144. Europe Human Rabies Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/unit) Table 145. Europe Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Human Rabies Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2026) & (k units) Table 148. Europe Human Rabies Vaccine (Vero Cell) Sales by Application (2027-2032) & (k units) Table 149. Europe Human Rabies Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/unit) Table 150. Europe Human Rabies Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/unit) Table 151. Europe Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Europe Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 155. Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2026) & (k units) Table 156. Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2027-2032) & (k units) Table 157. Europe Human Rabies Vaccine (Vero Cell) Sales Price by Country (2021-2026) & (US$/unit) Table 158. Europe Human Rabies Vaccine (Vero Cell) Sales Price by Country (2027-2032) & (US$/unit) Table 159. Germany Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 160. France Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 161. U.K. Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 162. Italy Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 163. Russia Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 164. Spain Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 165. Netherlands Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 166. Switzerland Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 167. Sweden Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 168. Poland Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 169. China Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 170. China Human Rabies Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 171. China Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2026) & (k units) Table 172. China Human Rabies Vaccine (Vero Cell) Sales by Type (2027-2032) & (k units) Table 173. China Human Rabies Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/unit) Table 174. China Human Rabies Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/unit) Table 175. China Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 176. China Human Rabies Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 177. China Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2026) & (k units) Table 178. China Human Rabies Vaccine (Vero Cell) Sales by Application (2027-2032) & (k units) Table 179. China Human Rabies Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/unit) Table 180. China Human Rabies Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/unit) Table 181. Asia Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Human Rabies Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2026) & (k units) Table 184. Asia Human Rabies Vaccine (Vero Cell) Sales by Type (2027-2032) & (k units) Table 185. Asia Human Rabies Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/unit) Table 186. Asia Human Rabies Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/unit) Table 187. Asia Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Human Rabies Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2026) & (k units) Table 190. Asia Human Rabies Vaccine (Vero Cell) Sales by Application (2027-2032) & (k units) Table 191. Asia Human Rabies Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/unit) Table 192. Asia Human Rabies Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/unit) Table 193. Asia Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia Human Rabies Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 197. Asia Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2026) & (k units) Table 198. Asia Human Rabies Vaccine (Vero Cell) Sales by Country (2027-2032) & (k units) Table 199. Asia Human Rabies Vaccine (Vero Cell) Sales Price by Country (2021-2026) & (US$/unit) Table 200. Asia Human Rabies Vaccine (Vero Cell) Sales Price by Country (2027-2032) & (US$/unit) Table 201. Japan Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 202. South Korea Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 203. India Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 204. Australia Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 205. Taiwan Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 207. SAMEA Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA Human Rabies Vaccine (Vero Cell) Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2026) & (k units) Table 210. SAMEA Human Rabies Vaccine (Vero Cell) Sales by Type (2027-2032) & (k units) Table 211. SAMEA Human Rabies Vaccine (Vero Cell) Sales Price by Type (2021-2026) & (US$/unit) Table 212. SAMEA Human Rabies Vaccine (Vero Cell) Sales Price by Type (2027-2032) & (US$/unit) Table 213. SAMEA Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA Human Rabies Vaccine (Vero Cell) Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2026) & (k units) Table 216. SAMEA Human Rabies Vaccine (Vero Cell) Sales by Application (2027-2032) & (k units) Table 217. SAMEA Human Rabies Vaccine (Vero Cell) Sales Price by Application (2021-2026) & (US$/unit) Table 218. SAMEA Human Rabies Vaccine (Vero Cell) Sales Price by Application (2027-2032) & (US$/unit) Table 219. SAMEA Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA Human Rabies Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 223. SAMEA Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2026) & (k units) Table 224. SAMEA Human Rabies Vaccine (Vero Cell) Sales by Country (2027-2032) & (k units) Table 225. SAMEA Human Rabies Vaccine (Vero Cell) Sales Price by Country (2021-2026) & (US$/unit) Table 226. SAMEA Human Rabies Vaccine (Vero Cell) Sales Price by Country (2027-2032) & (US$/unit) Table 227. Brazil Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 228. Argentina Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 229. Chile Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 230. Colombia Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 231. Peru Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 233. Israel Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 234. UAE Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 235. Turkey Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 236. Iran Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 237. Egypt Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. Human Rabies Vaccine (Vero Cell) Distributors List Table 241. Human Rabies Vaccine (Vero Cell) Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. Human Rabies Vaccine (Vero Cell) Image Figure 2. Global Human Rabies Vaccine (Vero Cell) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Rabies Vaccine (Vero Cell) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.5ml Image Figure 5. 1ml Image Figure 6. Global Human Rabies Vaccine (Vero Cell) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Rabies Vaccine (Vero Cell) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Human Rabies Vaccine (Vero Cell) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Figure 12. Global Human Rabies Vaccine (Vero Cell) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2021-2032) Figure 15. Global Human Rabies Vaccine (Vero Cell) Sales (2021-2032) & (k units) Figure 16. Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Human Rabies Vaccine (Vero Cell) Sales YoY (2021-2032) & (k units) Figure 19. Europe Human Rabies Vaccine (Vero Cell) Sales YoY (2021-2032) & (k units) Figure 20. China Human Rabies Vaccine (Vero Cell) Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Human Rabies Vaccine (Vero Cell) Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales YoY (2021-2032) & (k units) Figure 23. Global Human Rabies Vaccine (Vero Cell) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Human Rabies Vaccine (Vero Cell) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2021-2032) Figure 29. Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2021-2032) Figure 32. Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2021-2032) Figure 35. Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2021-2032) Figure 38. North America Human Rabies Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 39. North America Human Rabies Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 40. North America Human Rabies Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 41. North America Human Rabies Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 42. North America Human Rabies Vaccine (Vero Cell) Revenue Share by Country (2021-2032) Figure 43. North America Human Rabies Vaccine (Vero Cell) Sales Share by Country (2021-2032) Figure 44. Europe Human Rabies Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 45. Europe Human Rabies Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 46. Europe Human Rabies Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 47. Europe Human Rabies Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 48. Europe Human Rabies Vaccine (Vero Cell) Revenue Share by Country (2021-2032) Figure 49. Europe Human Rabies Vaccine (Vero Cell) Sales Share by Country (2021-2032) Figure 50. China Human Rabies Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 51. China Human Rabies Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 52. China Human Rabies Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 53. China Human Rabies Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 54. Asia Human Rabies Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 55. Asia Human Rabies Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 56. Asia Human Rabies Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 57. Asia Human Rabies Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 58. Asia Human Rabies Vaccine (Vero Cell) Revenue Share by Country (2021-2032) Figure 59. Asia Human Rabies Vaccine (Vero Cell) Sales Share by Country (2021-2032) Figure 60. SAMEA Human Rabies Vaccine (Vero Cell) Revenue Share by Type (2021-2032) Figure 61. SAMEA Human Rabies Vaccine (Vero Cell) Sales Share by Type (2021-2032) Figure 62. SAMEA Human Rabies Vaccine (Vero Cell) Revenue Share by Application (2021-2032) Figure 63. SAMEA Human Rabies Vaccine (Vero Cell) Sales Share by Application (2021-2032) Figure 64. SAMEA Human Rabies Vaccine (Vero Cell) Revenue Share by Country (2021-2032) Figure 65. SAMEA Human Rabies Vaccine (Vero Cell) Sales Share by Country (2021-2032) Figure 66. Human Rabies Vaccine (Vero Cell) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Human Rabies Vaccine (Vero Cell) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5ml
  • 1ml
Applications
  • Hospital
  • Clinic
Companies covered
  • Changchun Zhuoyi Biology
  • Ningbo Rong'an
  • Liaoning Chengda
  • Jilin Huikang Biopharmaceutical Co., Ltd.
  • Hualan Bio-vaccine
  • Guangzhou Nuocheng
  • Dalian Yali Peak
  • Chengdu Kanghua Biology
  • Serum Institute of India Pvt.
  • Sanofi Pasteur SA
  • Bharat Biotech
  • Bavarian Nordic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Rabies Vaccine (Vero Cell) Market by Type
  3. 1.2.1 Global Human Rabies Vaccine (Vero Cell) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.5ml
  5. 1.2.3 1ml
  6. 1.3 Human Rabies Vaccine (Vero Cell) Market by Application
  7. 1.3.1 Global Human Rabies Vaccine (Vero Cell) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Human Rabies Vaccine (Vero Cell) Market Dynamics
  1. 2.1 Human Rabies Vaccine (Vero Cell) Industry Trends
  2. 2.2 Human Rabies Vaccine (Vero Cell) Industry Drivers
  3. 2.3 Human Rabies Vaccine (Vero Cell) Industry Opportunities and Challenges
  4. 2.4 Human Rabies Vaccine (Vero Cell) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Rabies Vaccine (Vero Cell) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Region
  3. 3.2.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Rabies Vaccine (Vero Cell) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Rabies Vaccine (Vero Cell) Sales by Region
  9. 3.4.1 Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Rabies Vaccine (Vero Cell) Sales by Region (2021-2026)
  11. 3.4.3 Global Human Rabies Vaccine (Vero Cell) Sales by Region (2027-2032)
  12. 3.4.4 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturers
  2. 4.1.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Rabies Vaccine (Vero Cell) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Rabies Vaccine (Vero Cell) Sales by Manufacturers
  6. 4.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Rabies Vaccine (Vero Cell) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Rabies Vaccine (Vero Cell) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Rabies Vaccine (Vero Cell) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Rabies Vaccine (Vero Cell) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Rabies Vaccine (Vero Cell) Manufacturers, Product Type & Application
  13. 4.7 Global Human Rabies Vaccine (Vero Cell) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Rabies Vaccine (Vero Cell) Market CR5 and HHI
  16. 4.8.2 2025 Human Rabies Vaccine (Vero Cell) Tier 1, Tier 2, and Tier 3
5 Human Rabies Vaccine (Vero Cell) Market by Type
  1. 5.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Type
  2. 5.1.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Rabies Vaccine (Vero Cell) Sales by Type
  6. 5.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Rabies Vaccine (Vero Cell) Price by Type
6 Human Rabies Vaccine (Vero Cell) Market by Application
  1. 6.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Application
  2. 6.1.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Rabies Vaccine (Vero Cell) Sales by Application
  6. 6.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Rabies Vaccine (Vero Cell) Price by Application
7 Company Profiles
  1. 7.1 Changchun Zhuoyi Biology
  2. 7.1.1 Changchun Zhuoyi Biology Company Information
  3. 7.1.2 Changchun Zhuoyi Biology Business Overview
  4. 7.1.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolio
  6. 7.1.5 Changchun Zhuoyi Biology Recent Developments
  7. 7.2 Ningbo Rong'an
  8. 7.2.1 Ningbo Rong'an Company Information
  9. 7.2.2 Ningbo Rong'an Business Overview
  10. 7.2.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolio
  12. 7.2.5 Ningbo Rong'an Recent Developments
  13. 7.3 Liaoning Chengda
  14. 7.3.1 Liaoning Chengda Company Information
  15. 7.3.2 Liaoning Chengda Business Overview
  16. 7.3.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolio
  18. 7.3.5 Liaoning Chengda Recent Developments
  19. 7.4 Jilin Huikang Biopharmaceutical Co., Ltd.
  20. 7.4.1 Jilin Huikang Biopharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Jilin Huikang Biopharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolio
  24. 7.4.5 Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Hualan Bio-vaccine
  26. 7.5.1 Hualan Bio-vaccine Company Information
  27. 7.5.2 Hualan Bio-vaccine Business Overview
  28. 7.5.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolio
  30. 7.5.5 Hualan Bio-vaccine Recent Developments
  31. 7.6 Guangzhou Nuocheng
  32. 7.6.1 Guangzhou Nuocheng Company Information
  33. 7.6.2 Guangzhou Nuocheng Business Overview
  34. 7.6.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolio
  36. 7.6.5 Guangzhou Nuocheng Recent Developments
  37. 7.7 Dalian Yali Peak
  38. 7.7.1 Dalian Yali Peak Company Information
  39. 7.7.2 Dalian Yali Peak Business Overview
  40. 7.7.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolio
  42. 7.7.5 Dalian Yali Peak Recent Developments
  43. 7.8 Chengdu Kanghua Biology
  44. 7.8.1 Chengdu Kanghua Biology Company Information
  45. 7.8.2 Chengdu Kanghua Biology Business Overview
  46. 7.8.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolio
  48. 7.8.5 Chengdu Kanghua Biology Recent Developments
  49. 7.9 Serum Institute of India Pvt.
  50. 7.9.1 Serum Institute of India Pvt. Company Information
  51. 7.9.2 Serum Institute of India Pvt. Business Overview
  52. 7.9.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolio
  54. 7.9.5 Serum Institute of India Pvt. Recent Developments
  55. 7.10 Sanofi Pasteur SA
  56. 7.10.1 Sanofi Pasteur SA Company Information
  57. 7.10.2 Sanofi Pasteur SA Business Overview
  58. 7.10.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolio
  60. 7.10.5 Sanofi Pasteur SA Recent Developments
  61. 7.11 Bharat Biotech
  62. 7.11.1 Bharat Biotech Company Information
  63. 7.11.2 Bharat Biotech Business Overview
  64. 7.11.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolio
  66. 7.11.5 Bharat Biotech Recent Developments
  67. 7.12 Bavarian Nordic
  68. 7.12.1 Bavarian Nordic Company Information
  69. 7.12.2 Bavarian Nordic Business Overview
  70. 7.12.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolio
  72. 7.12.5 Bavarian Nordic Recent Developments
8 North America
  1. 8.1 North America Human Rabies Vaccine (Vero Cell) Market Size by Type
  2. 8.1.1 North America Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 8.1.3 North America Human Rabies Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 8.2 North America Human Rabies Vaccine (Vero Cell) Market Size by Application
  6. 8.2.1 North America Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 8.2.3 North America Human Rabies Vaccine (Vero Cell) Price by Application (2021-2032)
  9. 8.3 North America Human Rabies Vaccine (Vero Cell) Market Size by Country
  10. 8.3.1 North America Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Rabies Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Rabies Vaccine (Vero Cell) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Rabies Vaccine (Vero Cell) Market Size by Type
  2. 9.1.1 Europe Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Rabies Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 9.2 Europe Human Rabies Vaccine (Vero Cell) Market Size by Application
  6. 9.2.1 Europe Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Rabies Vaccine (Vero Cell) Price by Application (2021-2032)
  9. 9.3 Europe Human Rabies Vaccine (Vero Cell) Market Size by Country
  10. 9.3.1 Europe Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Rabies Vaccine (Vero Cell) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Rabies Vaccine (Vero Cell) Market Size by Type
  2. 10.1.1 China Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 10.1.2 China Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 10.1.3 China Human Rabies Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 10.2 China Human Rabies Vaccine (Vero Cell) Market Size by Application
  6. 10.2.1 China Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 10.2.2 China Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 10.2.3 China Human Rabies Vaccine (Vero Cell) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Rabies Vaccine (Vero Cell) Market Size by Type
  2. 11.1.1 Asia Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Rabies Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 11.2 Asia Human Rabies Vaccine (Vero Cell) Market Size by Application
  6. 11.2.1 Asia Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Rabies Vaccine (Vero Cell) Price by Application (2021-2032)
  9. 11.3 Asia Human Rabies Vaccine (Vero Cell) Market Size by Country
  10. 11.3.1 Asia Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Rabies Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Rabies Vaccine (Vero Cell) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Rabies Vaccine (Vero Cell) Market Size by Type
  2. 12.1.1 SAMEA Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Rabies Vaccine (Vero Cell) Price by Type (2021-2032)
  5. 12.2 SAMEA Human Rabies Vaccine (Vero Cell) Market Size by Application
  6. 12.2.1 SAMEA Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Rabies Vaccine (Vero Cell) Price by Application (2021-2032)
  9. 12.3 SAMEA Human Rabies Vaccine (Vero Cell) Market Size by Country
  10. 12.3.1 SAMEA Human Rabies Vaccine (Vero Cell) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Rabies Vaccine (Vero Cell) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Rabies Vaccine (Vero Cell) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Rabies Vaccine (Vero Cell) Value Chain Analysis
  2. 13.1.1 Human Rabies Vaccine (Vero Cell) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Rabies Vaccine (Vero Cell) Production Mode & Process
  6. 13.2 Human Rabies Vaccine (Vero Cell) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Rabies Vaccine (Vero Cell) Distributors
  9. 13.2.3 Human Rabies Vaccine (Vero Cell) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst